(Q36728938)

15 August 2017

1 reference

title

Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity (English)

1 reference

15 August 2017

0 references

9

Talley NJ

1 reference

15 August 2017

Bueno L

1

1 reference

15 August 2017

de Ponti F

2

1 reference

15 August 2017

Fried M

3

1 reference

15 August 2017

Kullak-Ublick GA

4

1 reference

15 August 2017

Kwiatek MA

5

1 reference

15 August 2017

Pohl D

6

1 reference

15 August 2017

Quigley EM

7

1 reference

15 August 2017

Tack J

8

1 reference

15 August 2017

1 January 2007

1 reference

Neurogastroenterology and Motility

15 August 2017

1 reference

15 August 2017

19

1 reference

15 August 2017

1 Suppl

1 reference

15 August 2017

89-119

1 reference

Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome

15 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Post-infectious irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Antinociceptive property of tegaserod in a rat model of chronic visceral hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Intestinal anti-nociceptive behaviour of NK3 receptor antagonism in conscious rats: evidence to support a peripheral mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Effect of asimadoline, a kappa opioid agonist, on pain induced by colonic distension in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Effect of CCK-1 antagonist, dexloxiglumide, in female patients with irritable bowel syndrome: a pharmacodynamic and pharmacogenomic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Corticotrophin-releasing factor receptors: from molecular biology to drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

The highly selective CRF(2) receptor antagonist K41498 binds to presynaptic CRF(2) receptors in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Stress-induced visceral hypersensitivity to rectal distension in rats: role of CRF and mast cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Acute stress-induced hypersensitivity to colonic distension depends upon increase in paracellular permeability: role of myosin light chain kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

The role of nerve growth factor in a model of visceral inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Role of nerve growth factor in the trinitrobenzene sulfonic acid-induced colonic hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Proteinases and proteinase-activated receptor 2: a possible role to promote visceral hyperalgesia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

The treatment of functional dyspepsia with red pepper

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Role of tension receptors in dyspeptic patients with hypersensitivity to gastric distention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

The role of tension receptors in colonic mechanosensitivity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

The influence of the novel 5-HT1A agonist R137696 on the proximal stomach function in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Functional chest pain: nociception and visceral hyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

An open-label trial of theophylline for functional chest pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Failure of oxethazaine to alter acid-induced esophageal pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Intrarectal lidocaine is an effective treatment for abdominal pain associated with diarrhea-predominant irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Gastrointestinal pharmacology: irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Influence of tegaserod on proximal gastric tone and on the perception of gastric distension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Tegaserod, a 5-HT4 receptor partial agonist, decreases sensitivity to rectal distension in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Efficacy of peripheral kappa agonist fedotozine versus placebo in treatment of irritable bowel syndrome. A multicenter dose-response study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

A randomized, controlled exploratory study of clonidine in diarrhea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Intrarectal injection of glycerol induces hypersensitivity to rectal distension in healthy subjects without modifying rectal compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Tachykinins and tachykinin receptors in the gut, with special reference to NK2 receptors in human

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Treatment of functional dyspepsia with antianxiety or antidepressive agents: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Evolution of visceral sensitivity in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Effect of the selective serotonin reuptake inhibitor sertraline on gastric sensitivity and compliance in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Influence of the selective serotonin re-uptake inhibitor, paroxetine, on gastric sensorimotor function in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Influence of acute serotonin reuptake inhibition on colonic sensorimotor function in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Influence of citalopram, a selective serotonin reuptake inhibitor, on oesophageal hypersensitivity: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Oral S(+)-ketamine does not change visceral perception in health

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

The development and maintenance of human visceral pain hypersensitivity is dependent on the N-methyl-D-aspartate receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Constitutive cyclo-oxygenase-2 does not contribute to the development of human visceral pain hypersensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Gabapentin reduces rectal mechanosensitivity and increases rectal compliance in patients with diarrhoea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Human cyclooxygenase-2 cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Effects of specific COX-2-inhibition on renin release and renal and systemic prostanoid synthesis in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

ABC of the upper gastrointestinal tract: Indigestion and non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Meta-analysis: upper gastrointestinal tolerability of valdecoxib, a cyclooxygenase-2-specific inhibitor, compared with nonspecific nonsteroidal anti-inflammatory drugs among patients with osteoarthritis and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Do changes in visceral sensory function determine the development of dyspepsia during treatment with aspirin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Gastric motility is an important factor in the pathogenesis of indomethacin-induced gastric mucosal lesions in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Dyspepsia tolerability from the patients' perspective: a comparison of celecoxib with diclofenac

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Constitutive expression and function of cyclooxygenase-2 in murine gastric muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Effects of aspirin and prostaglandin E2 on interdigestive motility complex and duodenogastric reflux in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Effect of cyclooxygenase-2 inhibitors on gastric emptying and small intestinal transit in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Regional cerebral activity in normal and pathological perception of visceral pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Differences in gastric mechanosensory function after repeated ramp distensions in non-consulters with dyspepsia and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Sensitization to mechanical stimulation by inflammatory mediators and by mild burn in canine visceral nociceptors in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Irritable bowel syndrome: new agents targeting serotonin receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Pharmacology of serotonin: what a clinician should know.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Plasticity in serotonin control mechanisms in the gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Review article: drugs interfering with visceral sensitivity for the treatment of functional gastrointestinal disorders--the clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Slow excitatory post-synaptic potentials in myenteric AH neurons of the guinea-pig ileum are reduced by the 5-hydroxytryptamine7 receptor antagonist SB 269970.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Regulation of 5-HT release from enterochromaffin cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Enteroendocrine cells and 5-HT availability are altered in mucosa of guinea pigs with TNBS ileitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Serotonin transporter function and expression are reduced in mice with TNBS-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Review article: intestinal serotonin signalling in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Peripheral neural serotonin receptors: identification and characterization with specific antagonists and agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

5-Hydroxytryptamine effects in the gut: the 3, 4, and 7 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

5-HT(2B) receptors play a key role in mediating the excitatory effects of 5-HT in human colon in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

5-HT7 receptors modulate peristalsis and accommodation in the guinea pig ileum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

From magic bullets to designed multiple ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Cilansetron: a new serotonergic agent for the irritable bowel syndrome with diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

The effect of the 5-HT3 receptor antagonist, alosetron, on brain responses to visceral stimulation in irritable bowel syndrome patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist Alosetron

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Lipid-induced colonic hypersensitivity in irritable bowel syndrome: the role of 5-HT3 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Tegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Distinct 5-HT receptors mediate the peristaltic reflex induced by mucosal stimuli in human and guinea pig intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

5-Hydroxytryptamine4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

The effects of tegaserod, a 5-HT receptor agonist, on gastric emptying in a murine model of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Serotonin type-4 receptors modulate the sensitivity of intramural mechanoreceptive afferents of the cat rectum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

5-HT4 receptor antagonism potentiates inhibition of intestinal allodynia by 5-HT3 receptor antagonism in conscious rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Activation of peripheral 5-HT receptors attenuates colonic sensitivity to intraluminal distension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Effects of tegaserod on Fos, substance P and calcitonin gene-related peptide expression induced by colon inflammation in lumbarsacral spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Tegaserod inhibits noxious rectal distention induced responses and limbic system c-Fos expression in rats with visceral hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Effect of tegaserod on esophageal pain threshold, regurgitation, and symptom relief in patients with functional heartburn and mechanical sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Evidence for 5-HT7 receptors mediating relaxation of human colonic circular smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Pharmacological characterization of the 5-HT receptors mediating contraction and relaxation of canine isolated proximal stomach smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

5‐HT7 receptors mediate the inhibitory effect of 5‐HT on peristalsis in the isolated guinea‐pig ileum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

5-HT7 receptors are involved in mediating 5-HT-induced activation of rat primary afferent neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Expression of 5-HT3 receptors by extrinsic duodenal afferents contribute to intestinal inhibition of gastric emptying

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Expression of 5-HT3 receptors in the rat gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Cloning of a serotonin transporter affected by antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Cloning and expression of a functional serotonin transporter from rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Pharmacological profile of antidepressants and related compounds at human monoamine transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Expression and function of 5-HT3 receptors in the enteric neurons of mice lacking the serotonin transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Review article: serotonin receptors and transporters -- roles in normal and abnormal gastrointestinal motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Adverse reactions of selective serotonin reuptake inhibitors: reports from a spontaneous reporting system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Tegaserod is effective in the initial and retreatment of irritable bowel syndrome with constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Serotonin transporter: gene, genetic disorders, and pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Serotonin transporter gene polymorphism in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Is there a SERT-ain association with IBS?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Disturbances of motility and visceral hypersensitivity in irritable bowel syndrome: biological markers or epiphenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Intestinal microecology and quality of life in irritable bowel syndrome patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Abnormal colonic fermentation in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Irritable bowel syndrome and inflammatory bowel disease: interrelated diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

DNA from probiotic bacteria modulates murine and human epithelial and immune function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Bacteriocins: developing innate immunity for food

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Lactobacillus farciminis treatment suppresses stress induced visceral hypersensitivity: a possible action through interaction with epithelial cell cytoskeleton contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Nitric oxide released by Lactobacillus farciminis improves TNBS-induced colitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Intestinal microflora and oral bacteriotherapy in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Single-blind follow-up study on the effectiveness of a symbiotic preparation in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome--a double blind, placebo-controlled, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

The use of probiotics in functional bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

The genetics of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Pharmacogenomics and functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Genes and the response to drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Pharmacogenomics and individualized drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Serotoninergic neuroenteric modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

The influence of Serotonin Transporter Promoter Polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Placebo response in studies of major depression: variable, substantial, and growing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

American gastroenterological association technical review on the evaluation of dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Association of distinct alpha(2) adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

A study of candidate genotypes associated with dyspepsia in a U.S. community

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

A prospective study characterizing full-length hepatitis B virus genomes during acute exacerbation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00876.X

10.1111/J.1365-2982.2006.00876.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference